Shire has been focusing on acquiring companies with treatments for rare conditions. Photograph: Simon Dawson/Bloomberg

Shire, the pharmaceutical company based in Dublin, is in advanced talks to acquire Baxalta for about $32 billion (€29.5 billion) in cash and stock, ex(...)

AstraZeneca agreed to buy a 55 per cent stake in Acerta Pharma for $4 billion to gain a potential blockbuster cancer medicine.

AstraZeneca agreed to buy a 55 per cent stake in Acerta Pharma for $4 billion to gain a potential blockbuster cancer medicine. The UK’s second-large(...)

Dr Jim Sullivan, vice-president of pharmaceutical discovery at AbbVie: “It is important in basic research to have the talent working well together.” Photograph: Eric Luke/The Irish Times

Ireland’s got talent in scientific research, but we need to keep investing it to attract even more. That’s according to Dr Jim Sullivan of global biop(...)

Gains at Airbus  and Renault  helped European stocks record their best month in more than six years yesterday.  Photographs: Pascal Rossignol.

European stocks recorded their best month in more than six years yesterday, buoyed by gains at carmaker Renault and aircraft maker Airbus while inves(...)

Teva factory sign on its plant in Jerusalem: Teva says its stock-and-cash offer of $82 a share represented a 48 per cent premium to Mylan’s stock price on March 10th, which it said was the last day of trading prior to the widespread speculation. Photograph: Menahem Kahana

Generic drugmaker Teva Pharmaceutical Industries Ltd yesterday proposed buying Mylan for $40 billion, saying it was a better deal than the smaller riv(...)

Shire  “trying to do the right thing” by running the pharmaceuticals company as efficiently as possible, says chief executive Flemming Ornskov

Shire’s chief executive has defended the company’s tax arrangements after being identified as one of the beneficiaries of alleged “industrial scale” (...)

Shire acting chief financial officer Jeff Poulton said the company had obtained advice that the break fee should not be taxable in Ireland. Photograph: The Irish Times

Drug giant Shire is facing a potential tax bill of up to €480 million as Irish Revenue officials examine the fallout from a collapsed takeover of the (...)

One of the two blocks at Woodford Business Park in Santry, Dublin 17 for which the freehold interest is up for sale

A high-quality office investment with strong opportunities to enhance its value in the vibrant office letting market goes on the market today at Woo(...)

Express Scripts, which will no longer offer Harvoni, manages pharmacy benefits for about 85 million people in the US

Gilead Sciences may finally be forced to offer a lower price for its $94,500 hepatitis C drug. The biotechnology company could have no choice but to n(...)

An office worker watching the FTSE 100, which slumped by another 2 per cent today as fears over the global economy triggered another bleak session for volatile stock markets. Photograph:  PA Wire

US stocks recovered from early losses as St. Louis Federal Reserve Bank President James Bullard said policy makers should consider delaying the end of(...)